Drug Profile
TGP 580
Alternative Names: CS 23Latest Information Update: 10 Oct 2000
Price :
$50
*
At a glance
- Originator Takeda
- Class Growth factors
- Mechanism of Action Angiogenesis inducing agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer
Most Recent Events
- 10 Oct 2000 Discontinued-I for Peptic ulcer in Japan (Transdermal)
- 10 Oct 2000 Discontinued-II for Peptic ulcer in United Kingdom (Unknown route)
- 10 Oct 2000 Discontinued-II for Peptic ulcer in USA (Unknown route)